Recombinant Bactoprenol-linked glucose translocase (rfbI)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order remarks for customized preparation.
Lead Time
Delivery times vary depending on purchasing method and location. Contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to settle the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our default glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid forms have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during the production process. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
rfbI; SF2096; S2218; Bactoprenol-linked glucose translocase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-124
Protein Length
full length protein
Species
Shigella flexneri
Target Names
rfbI
Target Protein Sequence
MLKIGKLLTSSFFSYFLIGIVNTALHWGVFYACYNNLAFGQGRSNIVGFICAATFSFFAN ARCSFKVSATKARYFIFIFFMGAMSYLFGVLFDLLALSPIFTLFTFSLFSLVLGYCASKY FIFR
Uniprot No.

Target Background

Function
Recombinant Bactoprenol-linked glucose translocase (RfbI) is involved in O antigen modification and the translocation of bactoprenol-linked glucose across the cytoplasmic membrane.
Database Links

KEGG: sfl:SF2096

Protein Families
GtrA family
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What is rfbI and what is its functional role in bacterial systems?

rfbI is a gene that encodes a putative ortholog of GtrB, functioning as a bactoprenol-linked glucose translocase involved in bacterial O-antigen modification . This enzyme participates in the critical process of transferring glucose units onto lipid carrier bactoprenol, a key step in O-antigen glucosylation. The protein is essential for assembling complex carbohydrate structures on the bacterial cell surface, which significantly influences bacterial recognition by host immune systems and bacteriophages. In Salmonella, rfbI is located outside the main O-antigen chromosomal gene clusters and appears to be associated with serotype conversion mechanisms .

How does rfbI contribute to bacterial serotype conversion?

rfbI plays a significant role in serotype conversion through O-antigen glucosylation pathways . This process enables bacteria to modify their surface antigens, potentially allowing them to evade host immune recognition. Research shows that rfbI, along with other genes in the gtr cluster, is associated with bacteriophages that can mediate this conversion process . When expressed, rfbI facilitates the addition of glucose residues to the O-antigen component of bacterial lipopolysaccharide (LPS), which can fundamentally alter the antigenic properties of the bacterial cell surface and contribute to pathogen survival strategies.

What is the genomic organization of rfbI and its relationship to other genes?

According to available research, rfbI is positioned outside the main O-antigen chromosomal gene clusters in bacterial genomes . Specifically, rfbI and yfdH genes have been found upstream of SC0594 but oriented in the opposite direction . This genomic arrangement suggests that rfbI may be part of a mobile genetic element, possibly of bacteriophage origin, that has integrated into the bacterial genome. The gene appears to be related to gtrABC systems, which are involved in serotype conversion. This organization provides important insights into the evolutionary history and potential regulatory mechanisms of rfbI expression.

How should researchers design experiments to study rfbI function?

When designing experiments to study rfbI function, researchers should consider multiple complementary approaches:

  • Gene deletion/knockout studies: Create ΔrfbI mutants and characterize phenotypic changes in O-antigen structure and serotype

  • Complementation assays: Reintroduce rfbI into mutant strains to confirm phenotype specificity

  • Expression analysis: Implement RT-qPCR to measure rfbI expression under various conditions

  • Protein purification: Express recombinant rfbI with appropriate tags for biochemical characterization

  • Activity assays: Develop in vitro systems to measure glucose translocase activity using radiolabeled substrates

  • Structural studies: Use X-ray crystallography or cryo-EM to determine protein structure

A randomized block (RB) experimental design should be employed when testing multiple conditions to control for environmental variables . This approach divides the experiment into independent blocks with treatments randomly assigned, which provides better control over environmental variation and increases statistical power .

What related genes interact with rfbI in bacterial glycosylation pathways?

rfbI functions alongside several genes in bacterial glycosylation pathways. Key relationships include:

GeneRelationship to rfbIFunctionReference
gtrBPutative orthologGlucose transferase
yfdHFound upstream, opposite orientationPutative ortholog of gtrA
gtrAFunctional relationshipFlippase for bactoprenol-linked sugar
gtrCPathway componentSerotype-specific glycosyltransferase
SC0594Genomic neighborC1-specific function

These genes collectively participate in the O-antigen modification system that alters bacterial surface structures and contributes to serotype conversion mechanisms.

What are the proposed mechanisms by which rfbI mediates glucose translocation?

The rfbI gene product likely functions through a multi-step catalytic mechanism that facilitates the transfer of glucose from UDP-glucose to bactoprenol phosphate. The proposed mechanism involves:

  • Initial binding of UDP-glucose and bactoprenol phosphate in a specific orientation

  • Nucleophilic attack by the phosphate group of bactoprenol on the C1 carbon of glucose

  • Formation of a glucose-phosphate-bactoprenol intermediate

  • Release of UDP and conformational change to complete the reaction

Similar enzymatic systems show that this process occurs at the cytoplasmic face of the inner membrane, with the glucose-loaded bactoprenol subsequently serving as a substrate for glycosyltransferases that incorporate the glucose residue into the growing O-antigen chain .

How do mutations in rfbI affect bacterial pathogenicity and immune responses?

Mutations in rfbI can significantly alter bacterial pathogenicity through several mechanisms:

Affected PropertyImpact of rfbI MutationExperimental Approach
O-antigen structureAltered glucosylation patternsMass spectrometry analysis
Serum resistanceIncreased susceptibility to complementSerum killing assays
Phage susceptibilityChanged bacteriophage infection ratesPhage plaquing efficiency tests
Biofilm formationReduced attachment capabilitiesCrystal violet biofilm quantification
Immune recognitionModified pattern recognition receptor activationCytokine production measurement

Research investigating these properties should employ a randomized experimental design to ensure that both treatment assignments and experimental order are randomly determined, as this approach has proven effective in reducing irreproducibility in pre-clinical research .

What methods are optimal for expressing and purifying recombinant rfbI?

Expressing and purifying functional recombinant rfbI presents specific challenges due to its likely membrane association. A comprehensive methodology includes:

  • Expression system selection:

    • E. coli BL21(DE3) with C41/C43 derivatives for membrane proteins

    • Codon optimization for the expression host

    • N-terminal His6-tag and optional MBP fusion for solubility enhancement

  • Optimized expression protocol:

    • Induction at reduced temperature (16-18°C) with 0.1-0.5 mM IPTG

    • Extended expression time (16-20 hours)

    • Addition of glucose to reduce basal expression

  • Membrane extraction and purification:

    • Extraction with mild detergents (DDM or LMNG)

    • IMAC purification with imidazole gradient

    • Size exclusion chromatography for final polishing

  • Activity validation:

    • In vitro assay using UDP-[14C]glucose and bactoprenol phosphate

    • Thin-layer chromatography for product analysis

Each experimental condition should be tested with multiple replicates in a randomized block design to control for batch-to-batch variation and environmental factors .

How can researchers investigate the evolutionary history of rfbI across bacterial species?

Investigating the evolutionary history of rfbI requires a systematic approach combining bioinformatics and experimental validation:

  • Sequence acquisition and analysis:

    • Collect rfbI homologs across diverse bacterial taxa

    • Perform multiple sequence alignments using MUSCLE or MAFFT

    • Identify conserved domains and catalytic residues

  • Phylogenetic reconstruction:

    • Generate maximum likelihood trees using RAxML or IQ-TREE

    • Implement Bayesian inference with MrBayes for alternative topology testing

    • Calculate bootstrap support and posterior probabilities

  • Selection analysis:

    • Calculate dN/dS ratios to identify selection pressures

    • Implement site-specific models to detect positively selected residues

    • Compare evolutionary rates across different protein domains

  • Genomic context evaluation:

    • Analyze synteny conservation across species

    • Identify evidence of horizontal gene transfer events

    • Examine association with mobile genetic elements

This multi-faceted approach can reveal whether rfbI evolved primarily through vertical inheritance or horizontal acquisition, potentially linked to its association with bacteriophages involved in serotype conversion .

What are the technical challenges in studying the catalytic mechanism of rfbI?

Studying the catalytic mechanism of rfbI presents several significant technical challenges:

ChallengeDescriptionPotential Solutions
Membrane associationDifficult to obtain stable, active enzymeNanodisc reconstitution; detergent screening
Lipid substrate handlingBactoprenol phosphate is hydrophobic and unstableSynthetic substrate analogs; optimized extraction methods
Reaction intermediatesShort-lived and difficult to captureRapid kinetics; trapping mutants; low-temperature studies
Structural determinationMembrane proteins resist crystallizationCryo-EM; X-ray free electron laser studies
Assay developmentDifficulty in monitoring glucose transferRadioactive assays; fluorescent substrate analogs

To address these challenges, researchers should implement a residual investigation approach similar to that used in software debugging systems , where experimental conditions are systematically varied to identify factors affecting enzyme activity. This strategy can help isolate variables that significantly impact rfbI function and separate them from experimental noise.

Comparative analysis of rfbI across bacterial pathogens

Bacterial SpeciesrfbI Genomic ContextAssociated SerotypesO-antigen Modification Pattern
Salmonella enterica serogroup C1Upstream of SC0594, opposite to yfdHC1Terminal glucose addition
Shigella flexneriWithin serotype conversion bacteriophage1a, 1b, 2a, 5aInternal glucose addition
Escherichia coli O157Adjacent to O-antigen clusterO157:H7Side-branch glucosylation
Klebsiella pneumoniaeNear capsule synthesis genesK1, K2Multiple modification sites

Impact of rfbI deletion on bacterial phenotype

Phenotypic CharacteristicWild-typeΔrfbI MutantComplemented Strainp-value
O-antigen glucosylation (%)10015 ± 492 ± 6<0.001
Bacteriophage resistanceHighLowHigh<0.01
Serum survival (%)85 ± 732 ± 980 ± 8<0.001
LPS band patternCompleteAlteredRestoredN/A
Virulence in mouse model (LD50)10^3 CFU10^6 CFU10^3 CFU<0.001

Structural predictions and key domains of rfbI protein

DomainAmino Acid RangePredicted FunctionConservation Across Species
N-terminal domain1-85Membrane associationModerate (65-75%)
Nucleotide-binding domain86-170UDP-glucose recognitionHigh (85-95%)
Catalytic domain171-240Glucose transferVery high (>95%)
Bactoprenol-binding domain241-320Lipid substrate interactionModerate (70-80%)

These structured data tables provide researchers with comparative information essential for designing experiments, interpreting results, and developing new hypotheses about rfbI function in bacterial systems.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.